HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying-Chun Dou Selected Research

fasudil (AT 877)

1/2016ROCK inhibitor abolishes the antibody response in experimental autoimmune myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying-Chun Dou Research Topics

Disease

6Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
11/2019 - 09/2013
3Experimental Autoimmune Neuritis
01/2019 - 02/2009
3Autoimmune Diseases (Autoimmune Disease)
01/2019 - 09/2013
2Myasthenia Gravis
01/2023 - 01/2018
2Guillain-Barre Syndrome
01/2019 - 01/2011
1Fatigue
01/2023
1Atopic Dermatitis (Atopic Eczema)
06/2006
1Inflammation (Inflammations)
06/2006

Drug/Important Bio-Agent (IBA)

4Atorvastatin (Lipitor)FDA Link
06/2019 - 01/2011
2CytokinesIBA
09/2013 - 01/2011
1AntibodiesIBA
01/2023
1AutoantibodiesIBA
01/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2019
1Sulfoglycosphingolipids (Sulfatides)IBA
01/2019
1Toll-Like Receptor 9IBA
01/2018
1OligodeoxyribonucleotidesIBA
01/2018
1fasudil (AT 877)IBA
01/2016
1Freund's AdjuvantIBA
01/2011
1Dehydroepiandrosterone (DHEA)IBA
02/2009
1Nerve Growth Factors (Neurotrophins)IBA
06/2006
1Nerve Growth Factor (NGF)IBA
06/2006

Therapy/Procedure

1Aftercare (After-Treatment)
11/2019
1Therapeutics
09/2013